SMA Research Platform

Evidence graph for Spinal Muscular Atrophy

Biology-first target discovery
Christian Fischer / Bryzant Labs
13,282Targets
453Trials
84Drugs
7Datasets
42,694Sources
48,101Claims
55,096Evidence
29,646Hypotheses
DRUGapprovedsmall molecule

FLUVASTATIN

Approved indications

cholesterol-hyperlipidemia

Related claims (0)

No claims matched “FLUVASTATIN” in free-text search.

Off-Target Findings (0)

No Boltz-2 / Chai-1 off-target panel claims recorded for this drug.

Login → Command Center